Clinical Trial: R-3750 in Patients With Mild to Moderate Ulcerative Colitis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Ulcerative Colitis Chronic Mild
Study Type: INTERVENTIONAL
Official Title: A Single and Repeat Dosing Study of the Safety, Drug Exposure, and Clinical Activity of R-3750 in Patients With Mild to Moderate Ulcerative Colitis
Brief Summary:
The goal of this study is to determine the safety and tolerability of orally taken probiotic (R-3750) in patients with mild to moderate ulcerative colitis.Patients will take an oral dosage of probiotic (R-3750) and provide patient-reported and physician scored measures of their colitis.Blood and fecal evaluations of inflammation and assessment of probiotic (R-3750) on fecal levels will also be measured.
Read more